Memorandum from NZSG

Posted Thursday April 6, 2023

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website


Related Articles

Commercial composting in the Green Endoscopy Unit- the next goal for waste reduction?

Friday April 19, 2024

Written and Shared by the NZSG Sustainability Working Group.

News Working Group Updates

Read more »

Gastro News from Around the Globe

Wednesday April 17, 2024

The Society receives information from many organisations around the globe as well as closer to home. We'd like to share ...

News Grants_Research

Read more »

FYI - Pharmacy Information

Tuesday April 16, 2024

An Alert multiple severe lead toxicity associated with the use of some Ayurvedic (traditional Indian medicine) products ...

Pharma News

Read more »